TTK Healthcare Limited
NSE: TTKHLTCARE · Diversified · sector
Key numbers
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 14 companies in Diversified (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹633 cr vs borrowings ₹24 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 35.9x in the last 12 months.
- Operating cash flow was below net profit in 4 of the last 5 years (FY26, FY25, FY24, FY23).
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 96% of net profit in the last 12 months.
- Dividend paid in 5 of the last 5 financial years.
- Price ₹993.10 on 2026-10-26: -20.4% from the 52-week high, +35.1% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 198 | 205 | 190 | 226 | 204 | 209 | 218 | 258 |
| EBITDA | 8 | 8 | 6 | 3 | 5 | -0 | 15 | 15 |
| OPM % | 4.1% | 3.8% | 3.2% | 1.2% | 2.6% | -0.2% | 6.7% | 5.7% |
| Other income | 18 | 18 | 19 | 18 | 19 | 17 | 18 | 17 |
| Net profit | 17 | 17 | 16 | 13 | 20 | 11 | 22 | 21 |
| EPS (₹) | 12.17 | 11.84 | 11.43 | 9.20 | 14.43 | 7.45 | 15.40 | 15.06 |
| Revenue YoY | +2.6% | +2.2% | +14.5% | +13.7% | ||||
| Profit YoY | +18.5% | -37.1% | +34.7% | +63.7% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 599 | 725 | 753 | 801 | 857 | 888 |
| EBITDA | 24 | 31 | 37 | 49 | 22 | 34 |
| Net profit | 42 | 640 | 63 | 82 | 66 | 74 |
| EPS (₹) | 29.43 | 452.72 | 44.47 | 57.79 | 46.48 | 52.34 |
| Revenue growth | +21.0% | +3.8% | +6.5% | +7.0% | +8.3% | |
| Profit growth | +1,438.1% | -90.2% | +29.9% | -19.6% | +17.2% | |
| Dividend / share (₹) | 6.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +5.7% | +6.1% | +8.3% |
| Net profit | -53.2% | +7.2% | +17.2% |
| EPS | -53.2% | +7.2% | – |
| Share price | – | -22.7% (2y) | -18.6% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 953 | 1,001 | 1,065 | 1,115 |
| Borrowings | – | 26 | 21 | 24 | 24 |
| Cash & equivalents | – | 847 | 775 | 786 | 633 |
| Total assets | – | 1,170 | 1,201 | 1,281 | 1,329 |
| Fixed assets | – | 71 | 75 | 81 | 73 |
| Capital work in progress | – | 3 | 1 | 0 | 1 |
| Investments | – | 13 | 13 | 11 | 9 |
| Receivables | – | 92 | 86 | 91 | 111 |
| Inventory | – | 85 | 97 | 109 | 109 |
| Payables | – | 124 | 102 | 107 | 91 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 45 | -26 | -5 | -4 | -21 |
| Cash from investing | -31 | 33 | 28 | 20 | 52 |
| Cash from financing | -9 | -12 | -22 | -18 | -18 |
| Capex | 6 | 12 | 10 | 13 | 6 |
| Free cash flow | 38 | -38 | -15 | -17 | -27 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 67.1% | 6.3% | 7.7% | 5.9% |
| ROCE % | – | 6.8% | 8.5% | 10.3% | 7.5% |
| Debtor days | – | 46 | 42 | 41 | 47 |
| Inventory days | – | 89 | 105 | 107 | 98 |
| Payable days | – | 131 | 110 | 106 | 83 |
| Cash conversion cycle (days) | – | 4 | 37 | 42 | 62 |
| Working capital days | – | 431 | 427 | 407 | 431 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 74.56% |
| FIIs | 1.95% |
| DIIs | 0.12% |
| Public (non-institutions) | 23.38% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 74.56% | 74.56% | 74.56% | 74.56% | 74.56% | 74.56% | 74.56% | 74.56% |
| Promoter group | % |
|---|---|
| T T Krishnamachari & Co. represented by its Partners -Mr T.T. Jagannathan and Mr T.T. Raghunnathan | 67.46% |
| Mukund Thiruvallur Thattai | 1.89% |
| Tiruvallur Thatai Lakshman | 1.89% |
| SARAYU THIRUVALLUR THATTAI (Duly represented by Ms. Maitri Gopalakrishna, her Mother and Natural Guardian) | 1.89% |
| Shanthi Ranganathan | 0.41% |
| Bhanu Raghunathan | 0.40% |
| T T Raghunathan | 0.27% |
| Latha Jagannathan | 0.21% |
| Packwell Packaging Products Limited | 0.06% |
| TTK Tantex Limited | 0.06% |
| TTK Prestige Limited | 0.01% |
| Stina Ostlund Vasu | 0.00% |
| Public holders above 1% | % |
|---|---|
| Foreign Institutional Investors | 1.95% |
| Jupiter India Fund | 1.52% |
| Investor Education and Protection Fund Authority | 1.09% |
| Equity Intelligence India Private Limited | 1.01% |
23,993 shareholders. Pledged: – of promoter shares.
Peers in Diversified
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| 3MINDIA | ₹32,937 cr | 57.0x | 18.6x | 32.0% | 51.7% | 19.2% | +10.9% | 1.83% |
| GODREJIND | ₹31,972 cr | 27.2x | 2.9x | 11.0% | 8.4% | 10.1% | +9.9% | 0.23% |
| DCMSHRIRAM | ₹15,179 cr | 10.5x | 2.0x | 19.5% | 12.1% | 10.9% | +5.7% | 1.08% |
| LORDSMARK | ₹2,966 cr | 34.5x | 3.0x | 16.8% | 9.7% | 13.2% | +1,739.5% | – |
| BALMLAWRIE | ₹2,623 cr | 9.4x | 1.3x | 13.8% | 15.6% | 13.2% | +5.4% | 8.04% |
| TTKHLTCARE | ₹1,403 cr | 19.0x | 1.3x | 6.8% | 8.5% | 3.9% | +5.7% | 1.01% |
| EMPIND | ₹560 cr | 10.0x | 1.6x | 16.9% | 18.4% | 12.1% | +2.4% | 2.67% |
| PANTH | ₹46 cr | 0.9x | 0.5x | 78.9% | 30.3% | 17.1% | +161.7% | – |
| KRYPTONQ | ₹41 cr | 14.7x | 1.3x | 8.9% | 11.6% | 13.5% | +16.8% | 3.58% |
| SVARTCORP | ₹28 cr | 5.7x | 0.9x | 17.0% | 19.3% | 24.2% | +35.8% | – |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Consumer Products | ₹241 cr | 28.1% | ₹18 cr | 7.6% |
| Protective Devices | ₹216 cr | 25.3% | ₹-10 cr | -4.9% |
| Foods | ₹151 cr | 17.6% | ₹13 cr | 8.9% |
| Animal Welfare | ₹141 cr | 16.5% | ₹12 cr | 8.4% |
| Medical Devices | ₹107 cr | 12.5% | ₹22 cr | 21.1% |
| Others | ₹0 cr | 0.0% | ₹0 cr | 101.8% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-07-17 | Dividend | Dividend - Rs 10 Per Share |
| 2025-07-18 | Dividend | Annual General Meeting/Dividend - Rs 10 Per Share |
| 2024-07-16 | Dividend | Annual General Meeting/Dividend - Rs10 Per Sh/ |
| 2023-07-18 | Dividend | Annual General Meeting/Dividend - Rs 10 Per Share |
| 2022-07-26 | Dividend | Annual General Meeting/Dividend - Rs 10 Per Share |
| 2021-08-12 | Dividend | Annual General Meeting/Dividend - Rs 6 Per Share |
| 2020-09-03 | Dividend | Annual General Meeting/Dividend - Rs 3 Per Share |
| 2019-08-01 | Dividend | Annual General Meeting/Dividend - Rs 5 Per Share |
| 2018-08-02 | Dividend | Annual General Meeting/Dividend- Rs 5 Per Share |
| 2017-07-27 | Dividend | Annual General Meeting/Dividend - Rs 5 Per Share |
| 2016-07-28 | Dividend | Annual General Meeting/ Dividend - Rs 5 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
| Sector | Diversified |
| Industry | Diversified |
| Sub-industry | Diversified |
| Symbol | TTKHLTCARE |
| BSE code | 507747 |
| ISIN | INE910C01018 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.